MyoGene Bio: Valuation, Funding & Investors
https://www.myogenebio.com/Therapeutics
A privately held biotech company based in San Diego, CA dedicated to developing next-generation genetic therapies for Duchenne and other muscle diseases. The company's lead program is a gene editing therapy for Duchenne muscular dystrophy.
Leadership & Board
- Current Number of Employees
- 5
- Current LinkedIn Followers
- 948
Latest Estimated Valuation
- Total Amount Raised
- $400K
- Total Funding Rounds
- 1
- Latest Funding Amount
- $400K
- Latest Funding Round
- Investment
Employee Trend
MyoGene Bio had 5 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
5Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
MyoGene Bio had 948 followers as of October 26, 2026. The number of followers increased by 5 (0.53%) week-over-week.
948Latest Followers Count
5(0.53%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Nov 04, 2025 | Investment | $400.00K | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Parent Project Muscular Dystrophy | Investment |
| Duchenne UK | Investment |
| How Women Invest | Investment |
Similar Companies
A snapshot of private companies similar to MyoGene Bio, helping you discover and navigate related company profiles.
Related News and Analysis
